Capitainer appoints DBS pioneer Donald H. Chace to spearhead US market entry for its next generation dried blood sampling technology
Stockholm, Sweden January 25, 2022 – Swedish medtech Capitainer today announced that Dr Donald H. Chace has been appointed as Capitainer representative for North Americas. Bringing a wealth of experience covering Neonatology, Clinical Chemistry, Newborn Screening, Mass Spectrometry and Forensic Science, he joins the team as Capitainer looks to penetrate the US market with their proprietary qDBS dried blood sampling technology. Dr Chace is also a longstanding advocate of DBS testing being of one of the primary developers of the newborn metabolic screening test known as Tandem Mass